Could cause temporary or reversible harm; serious harm is unlikely.
CGMP Deviations: N-nitroso-quinapril and N-nitroso-hydrochlorothiazide impurity above the acceptable daily intake limit.
| Distributed by / for | Parke-Davis, Division of Pfizer Inc, NY, NY 10017 |
| NDC | 0071-0223-23 |
| Full product label | Accuretic (quinapril HCl/hydrochlorothiazide) Tablets, 20 mg/25 mg, 90 tablets bottles, Rx Only, Distributed by: Parke-Davis, Division of Pfizer Inc, NY, NY 10017, Made in Germany, NDC 0071-0223-23. |
| Recalling firm | Pfizer Inc. |
| Distribution | Nationwide |
| Quantity | 265 bottles |
| Recall initiated | 2022-03-21 |
| Report date | 2022-04-13 |
| Recall completed | 2024-08-28 |
| Recall number | D-0757-2022 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | New York NY United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗